At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 48 enrolled
Drug / intervention
Parafon Fortedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Placebo-Controlled Cross Over Trial of Chlorzoxazone Intake
In Brief
A Phase 4 clinical trial evaluating Parafon Forte for Alcohol Abuse. Completed, enrolled 48 participants across 1 site.
Detailed Summary
The overall goals of this study are to (1) expand knowledge about interactions of chlorzoxazone with alcohol by assessing the effects of chlorzoxazone compared to placebo in moderate and heavy social alcohol users and (2) to compare the effects of chlorzoxazone on visual cue induced alcohol craving to placebo in moderate to heavy social alcohol users.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcohol Abuse
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2011
First PostedApr 2011
Primary CompletionApr 2013
Study CompletionDec 2013
TodayJul 2026
First PostedApr 27, 2011
Enrollment StartApr 1, 2011
Primary CompletionApr 1, 2013
Study CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 15.2 years ago
Interventions
Parafon Fortedrug
Drug: Parafon Forte administered at study visit Other: Placebo administered at study visit